Suchergebnisse - "Schifferli, Kevin"

PubPharm (9)

1

Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12

enthalten in: Molecular therapy. Oncology | 2024

von Kurokawa, C. | Agrawal, S. | Mitra, A. | +19

2

Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy

enthalten in: Cytotherapy | 2022

von Giardino Torchia, M. | Gilbreth, R. | Merlino, A. | +15

3

Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors

enthalten in: Nature communications | 2019

von Sale, M. | Minihane, E. | Monks, N. | +15

CommentIn: Nat Commun. 2020 Jan 27;11(1):531. - PMID 31988312

4

Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer

enthalten in: Molecular cancer therapeutics | 2018

von Cho, S. | Zammarchi, F. | Williams, D. | +31

5

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus

enthalten in: Lupus science & medicine | 2018

von Riggs, J. | Hanna, R. | Rajan, B. | +13

6

A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities : Differential Impacts of PTEN Status on Tumor Response

enthalten in: Molecular cancer therapeutics | 2016

von Xiao, Z. | Carrasco, R. | Schifferli, K. | +13

7

A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response

enthalten in: Molecular cancer therapeutics | 2016

von Xiao, Z. | Carrasco, R. | Schifferli, K. | +13

8

A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways

enthalten in: Molecular cancer therapeutics | 2015

von Rios-Doria, J. | Sabol, D. | Chesebrough, J. | +18

9

A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways

enthalten in: Molecular cancer therapeutics | 2015

von Rios-Doria, J. | Sabol, D. | Chesebrough, J. | +18

1
[1]